Abstract:Background: The concept of the gut-retinal axis proposed by previous scholars primarily focused on the relationship between intestinal microbiota and retinal diseases, and few further expanded the relationship between intestinal diseases and retinal diseases. To further substantiate the concept of the gut-retinal axis, we analyzed inflammatory bowel disease (IBD) and diabetic retinopathy (DR) using Mendelian randomization (MR), and use mediation analysis to further explore the potential substances that influence this causal relationship. Methods: The genome-wide association study's (GWAS) summary statistics for genetic variations were utilized in a Mendelian randomization (MR) investigation. GWAS data on IBD (including ulcerative colitis (UC), Crohn's disease (CD), and IBD) for non-Finnish Europeans (NFE) were sourced from published articles. In contrast, data on DR (including DR and diabetic maculopathy (DMP)) were obtained from FinnGen R9. The causal relationship has been investigated using inverse variance weighted (IVW), MR-Egger, and weighted median and sensitivity analysis was applied to verify the stability of the results. In addition, we applied mediation analysis to investigate whether circulating inflammatory proteins and plasma lipids played a mediating role, and calculated its effect ratio. Results: The causal relationship between IBD and DR was discovered by employing the inverse variance weighted (IVW) method and weighted median method. In forward MR, UC was significantly associated with lower risk of DR (IVW: OR=0.874; 95%CI= 0.835–0.916; P value= 1.28E-08) (Weighted median: OR=0.893; 95%CI= 0.837–0.954; P value= 7.40E-04). In reverse MR, it was shown that DR (IVW: OR=0.870; 95%CI= 0.828–0.914; P value= 2.79E-08)(Weighted median: OR=0.857; 95%CI= 0.801–0.916; P value= 6.40E-06) and DMP (IVW: OR=0.900; 95%CI= 0.865–0.937; P value= 3.34E-07)(Weighted median: OR=0.882; 95%CI= 0.841–0.924; P value= 1.82E-07) could reduce the risk of CD. What's more, DR is associated with a lower risk of IBD according to genetic prediction (IVW: OR=0.922; 95%CI= 0.873–0.972; P value= 0.002) (Weighted median: OR=0.924; 95%CI= 0.861–0.992; P value= 0.029). Fibroblast growth factor 21 (FGF21), phosphatidylcholine (PC), and triacylglycerol (TG) serve as mediators in these relationships. Conclusions: Our research offers novel insights and sources for investigating the gut-retina axis in the genetic relationship between IBD and DR. We discover four mediators and more about the association between the intestine and retinal disorders and provide more evidence for the gut-retinal axis theory.

Causal effects of gut microbiota on diabetic retinopathy: A Mendelian randomization study

Association between gut microbiota and diabetic microvascular complications: a two-sample Mendelian randomization study

Causal relationship between T2DM microvascular complications and gut microbiota: a Mendelian randomization study

Association between gut microbiota and diabetic nephropathy: a mendelian randomization study

Assessing the causal relationship between gut microbiota and diabetic nephropathy: insights from two-sample Mendelian randomization

Causal relationship between gut microbiota and diabetic nephropathy: a two-sample Mendelian randomization study

Exploring the Causal Effects of Gut Microbiota on Diabetic Nephropathy: A Two-Sample Mendelian Randomization Study

Association of the gut microbiota with coronary artery disease and myocardial infarction: A Mendelian randomization study

Genetic Evidence for the Causal Relationship Between Gut Microbiota and Diabetic Kidney Disease: A Bidirectional, Two‐Sample Mendelian Randomisation Study

Causal influence of immune factors on the risk of diabetic retinopathy: a mendelian randomization study

Investigating the causal link between gut microbiota and dry age-related macular degeneration: a bidirectional Mendelian randomization study

Effect of the Gut Microbiome in Glaucoma Risk from the Causal Perspective

Causal effects of gut microbiota on diabetic neuropathy: a two-sample Mendelian randomization study

Causal relationships between gut microbiota, gut metabolites, and diabetic neuropathy: A mendelian randomization study

Causal association of circulating metabolites with diabetic retinopathy: a bidirectional Mendelian randomization analysis

Causal relationship of gut microbiota with diabetic nephropathy: a Mendelian randomization analysis

Assessing the relationship between gut microbiota ( family, orders, classes,and phyla) and gestational diabetes mellitus : a two-sample Mendelian randomization analysis

Exploring the Effect of the Gut Microbiome on the Risk of Age-Related Macular Degeneration from the Perspective of Causality.

Causal effect of gut microbiota and diabetic nephropathy: a Mendelian randomization study

Mendelian randomization study and mediation analysis about the relation of inflammatory bowel disease and diabetic retinopathy: the further exploration of gut-retina axis

Causal effect between gut microbiota and pancreatic cancer: a two-sample Mendelian randomization study